Stay updated with breaking news from Nasdaq Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Quarry LP boosted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 106.7% during the first quarter, Holdings Channel.com reports. The institutional investor owned 674 shares of the biopharmaceutical company’s stock after buying an additional 348 shares during the period. Quarry LP’s holdings in Regeneron Pharmaceuticals were worth $554,000 as of […]
Delphia USA Inc. purchased a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 603 shares of the biopharmaceutical company’s stock, valued at approximately $495,000. Several other hedge funds have also recently modified their […]
Nissay Asset Management Corp Japan ADV lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 13,047 shares of the biopharmaceutical company’s stock after selling 416 shares […]
Two Sigma Investments LP raised its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 488.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 189,295 shares of the biopharmaceutical company’s stock after buying an additional 157,137 shares during […]
Two Sigma Advisers LP boosted its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 332.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 209,800 shares of the biopharmaceutical company’s stock after purchasing an additional 161,300 […]